ROCK CREEK PHARMACEUTICALS, INC. (CIK: 0000776008) EDGAR, Information, Filings... CompaniesBIO.Com

ROCK CREEK PHARMACEUTICALS, INC.

Mailing address
2040 WHITFIELD AVENUE, SUITE 300, SARASOTA, Delaware, 34243
Phone
804-527-1970
State location
Florida
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Filings
N/A

ROCK CREEK PHARMACEUTICALS, INC. (CIK: 0000776008) is an American company incorporated in the state of Florida. Head office is located at 2040 WHITFIELD AVENUE, SUITE 300, SARASOTA, Florida, 34243. Work in the industry 2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS. ROCK CREEK PHARMACEUTICALS, INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

STAR SCIENTIFIC INC from 1999-10-May to 2014-02-Jun
EYE TECHNOLOGY INC from 1996-11-Sep to 1998-17-Feb

Owner	Filings	Transaction Date	Type of Owner
Scannell Robert	0001604257	Nov-17-2015	director
McMahon William L	0001359663	Aug-14-2015	officer: CFO and Treasurer
SAMUEL SUNITHA CHUNDRU	0001640062	Apr-20-2015	director
CANAAN LEE M	0001134252	Aug-01-2014	director
McDONNELL EDWARD J.	0001617930	Aug-01-2014	director
Tradewinds Capital, L.P.	0001548550	Apr-02-2014	other: See Remarks
Tradewinds Fund (Cayman), Ltd.	0001548551	Apr-02-2014	10 percent owner
Dent Benjamin M	0001594991	Dec-27-2013	director
Sensenbrenner Scott P	0001595167	Dec-27-2013	director
Mullan Michael J	0001595196	Dec-27-2013	director, officer: Chief Executive Officer
Whittel Naomi	0001595263	Dec-27-2013	director
Wilson Thomas L	0001595266	Dec-27-2013	director
PERITO PAUL L	0001087905	Dec-24-2013	director, officer: President & COO
EVERETT RALPH B	0001243427	Dec-14-2013	director
Haynes Burton J.	0001504151	Oct-22-2013	director
Chapman Christopher C JR	0001340428	Sep-22-2013	director
Chayet Neil L	0001412566	Sep-07-2013	director
POKUSA ROBERT E	0001280485	Apr-05-2012	officer: General Counsel
DEAN DAVID MICHAEL	0001301584	Apr-05-2012	officer: V.P. Sales & Marketing
Dodd Park A III	0001414533	Apr-05-2012	officer: Chief Financial Officer
Wright Curtis IV	0001429992	Apr-05-2012	officer: Senior Vice President
Mirabelli Mario V.	0001497622	Apr-05-2012	director
WILLIAMS JONNIE	0001056017	Dec-31-2011	director, 10 percent owner, officer: CEO
SHARP RICHARD L	0000939448	Mar-17-2011	director
Peters Scott	0001444109	Sep-14-2008	other: Less than 10% owner
Feehan Partners, L.P.	0001445823	Sep-14-2008	other: Less than 10% owner
P.V. Partners, L.P.	0001445824	Sep-14-2008	other: Less than 10% owner
Tradewinds Master Fund (BVI) Ltd.	0001445825	Sep-14-2008	other: Less than 10% owner
Weichelbaum Alan	0001412577	Sep-07-2007	director
OKEN MARC D	0001189900	Oct-11-2005	director
Vorhoff David C	0001342020	Oct-11-2005	director
Carmen Gerald Posner	0001319042	Sep-22-2005	director
MILLER CHRISTOPHER G	0001248332	Apr-21-2005	officer: Chief Financial Officer
KELLEY WHITMORE B	0001248329	Apr-13-2004	director
BARTELS JOHN R	0001248326	Jan-28-2004	director
TONKIN LEO S	0001073828	Nov-20-2003	director
ODONNELL KATHLEEN M TR IRREV TR 1 FBO FRANCIS E ODONNELL JR	0001262022	Aug-18-2003	10 percent owner
LAMB PAUL H III	0000905598	Dec-11-1998	officer: Pres. of Star Tobacco, Inc.

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ROCK CREEK PHARMACEUTICALS, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
REVOKED	Document	Acc-no: 9999999997-23-000566 (34 Act) Size: KB	Feb-14-2023	000-15324 23623663
8-K	Document	Current report filing Acc-no: 0001144204-16-125682 (34 Act) Size: KB	Sep-28-2016	000-15324 161906062
8-K	Document	Current report filing Acc-no: 0001144204-16-121799 (34 Act) Size: KB	Aug-29-2016	000-15324 161858503
8-K	Document	Current report filing Acc-no: 0001144204-16-119927 (34 Act) Size: KB	Aug-17-2016	000-15324 161837794
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-16-118075 (34 Act) Size: KB	Aug-10-2016	000-15324 161822156
DEF 14A	Document	Definitive proxy statements Acc-no: 0001144204-16-114030 (34 Act) Size: KB	Jul-22-2016	000-15324 161778537
PRE 14A	Document	Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001144204-16-112442 (34 Act) Size: KB	Jul-11-2016	000-15324 161762588
8-K	Document	Current report filing Acc-no: 0001144204-16-112269 (34 Act) Size: KB	Jul-08-2016	000-15324 161759957
8-K	Document	Current report filing Acc-no: 0001144204-16-112109 (34 Act) Size: KB	Jul-08-2016	000-15324 161757666
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001144204-16-112110 (34 Act) Size: KB	Jul-08-2016	000-15324 161757662
8-K	Document	Current report filing Acc-no: 0001144204-16-102768 (34 Act) Size: KB	May-16-2016	000-15324 161654989
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001144204-16-102758 (33 Act) Size: KB	May-16-2016	333-211400 161654935
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-16-102745 (34 Act) Size: KB	May-16-2016	000-15324 161654884
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001144204-16-097947 (33 Act) Size: KB	Apr-29-2016	333-208016 161608587
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-16-097796 (34 Act) Size: KB	Apr-29-2016	000-15324 161606585
D	Document	Acc-no: 0000897069-16-000799 (33 Act) Size: KB	Apr-13-2016	021-261206 161568683
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001144204-16-093015 (33 Act) Size: KB	Apr-06-2016	333-208016 161558103
8-K	Document	Current report filing Acc-no: 0001144204-16-092819 (34 Act) Size: KB	Apr-05-2016	000-15324 161555256
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001140361-16-059675 ( Act) Size: 0 KB	Mar-31-2016
8-K	Document	Current report filing Acc-no: 0001144204-16-091760 (34 Act) Size: KB	Mar-31-2016	000-15324 161541727

Recent 20 filings. View all ROCK CREEK PHARMACEUTICALS, INC. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

ROCK CREEK PHARMACEUTICALS, INC. overview
ROCK CREEK PHARMACEUTICALS, INC. job
ROCK CREEK PHARMACEUTICALS, INC. stock
ROCK CREEK PHARMACEUTICALS, INC. ownership
ROCK CREEK PHARMACEUTICALS, INC. CEO
ROCK CREEK PHARMACEUTICALS, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.